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Chrysanthemum cinerariifolium (C.cinerariifolium) is a plant of the 
Asteraceae family, which has been applied by the community as an 
ornamental plant and traditional medicine. In this study, the effect of C. 
cinerariifolium leaves extract on inhibition of cell cycle and induction of 
apoptosis in T47D breast cancer cells was tested and compared to the 
standard chemotherapy agent. The citotoxic activity of C. cinerariifolium 
leaves extract against T47D cancer cells and Vero normal cells was tested by 
MTT method. Profile of apoptosis and cell cycle were observed by flow 
cytometry method. Based on chemical compounds profil which is tested 
used TLC showed that C.cinerariifolium leaves extracts contained flavonoid 
and terpenoid chemical compounds. The result of cytotoxic test showed that 
leaves extract of C. cinerariifolium was able to inhibit the growth of T47D 
cancer cell at IC50 418.8μg/mL. Doxorubicin, extracted from Streptomyces 
peucetius used as treatment in several cancers including breast cancer. 
Doxorubicin could inhibit the growth of T47D cancer cells in 115.1μg/mL. 
The results of cell cycle analysis showed that the C. cinerariifolium leaves 
extract inhibited cell cycle in G0-G1 and S phase, whereas doxorubicin was 
able to inhibit cell cycle in G0-G1 phase but experienced cell accumulation in 
G2-M phase. The percentage of apoptosis in cycle was showed in M1 (sub 
G1) and M5 (multinuclear) phase which treatment of C. cinerariifolium 
leaves extract was higher than doxorubicin. Therefore, C. cinerariifolium 
leaves extract has potential activity as anticancer agent causes inhibition of 
cell cycle and induction apoptosis. 
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INTRODUCTION 
Breast cancer is a malignancy that occurs in 
cells contained in breast tissue, and both derived 
from the components of the glands (ductal 
epithelial or globulus) and those derived from 
components other than glands such as tissue 
nerves in the breast, fat tissue, and blood vessels 
(Sari et al., 2017). American Cancer Society 
revealed in its latest data that by the year 2013, 
every year there are about 39,620 women died 
caused by breast cancer (DeSantis et al., 2014).  
Breast cancer treatment efforts such as the 
use of chemotherapy agents, radiation, 
radiotherapy has widely used. Doxorubicin is a 
chemotherapy drug widely used in the treatment of 
breast cancer. However, the use of chemotherapy 
drugs is decreased because of the risk of side   
effects   that   often occur, such as resistance and 
cardiomyopathy (Octavia et al., 2012). Therefore, 
to minimize the occurrence of side effects used 
traditional medicine using herbs. One of them is 
chrysanthemum (Chrysanthemum cinerariifolium). 
Crhysanthemum cinerariifolium (C. 
cinerariifolium) is a plant of the Asteraceae family 
that has been used by the community as an 
ornamental plant because of its beautiful flowers. 
Various plant organs can utilized as drugs such as 
antibacterial, anti-inflammatory, allergy, and also 
anticancer (Grdisa et al., 2009). Based on previous 
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research indicates that the extract of 
Chrysanthemum zawadskii flower and leaves has 
pharmacological activity, is as an anti-
inflammatory by inhibition of lipopolysaccharide 
on RAW264.7 cell induced by nitrite oxide (Kim et 
al., 2012). 
The previous study showed that 
Chrysanthemum contain terpenoid compounds, 
flavonoids, and derivatives that are suspected                    
of having anticancer activity (Ukiya et al., 2002). 
Previous research has also reported that                               
C. cinerariifolium comprises a quercetin             
compound (Jeong et al., 2012; Alviana et al.,              
2016). The quercetin compound is thought to have 
an anticancer effect through the induction of the 
p21 gene which is a CDK inhibitor, along with a 
decline in Rb gene that inhibits cell cycle in G1 / S 
phase by inhibiting E2F (Yerlikaya et al., 2017). 
Scientific evidence of anticancer activity of 
chrysanthemum plants with C. cinerariifolium 
species has not widely performed in both apoptotic 
and cell cycle testing. In this study reported the 
effects of C. cinerariifolium extract on apoptosis 
induction and regulation of breast cancer cell cycle 
T47D. 
 
MATERIAL AND METHODS 
The materials used in this study were C. 
cinerariifolium leaves, 96% ethanol, distilled water, 
n-Hexane p. a, ethyl acetate p.a, 10% H2SO4, T47D 
cells and Vero cells obtained from Parasitology 
Laboratory Faculty of Medicine Gajah Mada 
University, Yogyakarta, Complete Medium (CM) 
RPMI 1640 (Gibco, Invitrogen Canada), CM MI99 
(Gibco, Invitrogen Canada), PBS, Trypsin-EDTA, 
DMSO (EMSURE ACS, Japan), SDS (Merck, Berlin 
Germany), doxorubicin HCL 50 mg, MTT solution  
(Bio Basic Inc, Canada), trypsin-EDTA 0,25% 
(Gibco, Invitrogen Canada), RNAse (Gibco, 
Invitrogen Canada), propidium iodide (Sigma-
Aldrich, USA), triton-X (pro GC Merck, Berlin, 
Germany) and Annexin V (Sigma-Aldrich, USA). 
 
Plant determination 
C. cinerariifolium (Trev.) plants were 
obtained from Nongkojajar, Pasuruan, East Java, 
Indonesia. Determination of C. cinerariifolium plant 
was conducted in Materia Medika Integrated 
Service Unit Batu City, East Java, Indonesia. 
 
Ethical approval  
This study has received ethical approval No. 
002/EC/KEPK-FKIK/2018 from Medical Research 
Ethics Committee of Faculty of Medicine and Health 
Sciences Maulana Malik Ibrahim State Islamic 
University of Malang. 
 
Sample preparation 
Samples of C. cinerariifolium were harvested 
by cutting on the leaves using scissors. Then begins 
by sorting each section, washed, dried under the 
sun, and final sorting. Dry samples are mashed up 
with grinding machines and weighed C. 
cinerariifolium leaves powder. 
Extraction of C. cinerariifolium 
Leaves powder of C. cinerariifolium was put 
into the Erlenmeyer flask and 96% ethanol solvent 
was added with a ratio of 1: 20. Then extracted 
using UAE (Ultrasonication Assisted Extraction) for 
2 min with three replications. The leaves filtrate C. 
cinerariifolium of the UAE evaporated the solvent 
using a rotary evaporator at 50°C temperature to 
produce a crude extract. The sticky extract was 
concentrated using an oven at 40°C temperature 
until the texture of the extract became 
concentrated. Then calculated extracted yield using 
the formula: 
Extracted yield =
Extract weight
Raw material weight
× 100% 
 
Identification of compounds used Thin Layer 
Chromatography (TLC) 
In the identification of compounds, the silica 
gel 60 F254 used as a stationary phase with the                
n-Hexane p. a (Merck, Berlin, Germany) and                
ethyl acetate p.a (Merck, Berlin, Germany) (8: 2) 
periods of motion. The stain used was 10% H2SO4. 
Identify stain compounds using Thin Layer 
Chromatography (TLC) Visualizer. 
 
Sample preparation for anticancer activity and 
toxicity test  
Leaves extract was weighed as much as 
10mg, dissolved with 100μg/mL DMSO and made 
seven serial concentrations in T47D cells were 
1000; 800; 600; 400; 200; 100; 50μg/mL and in 
Vero cells were 1000; 500; 250; 125; 62,5; 31,25; 
15.625µg/mL. While doxorubicin positive control 
was made seven serial concentrations, in T47D 
cells were 1087.04; 543.52; 271.76; 135.88; 67.94; 
33.97; 16.985µg/mL and in Vero cells were 5435; 
2717.60; 1358.80; 679.40; 339.70; 169.85; 84,925 
µg/mL. 
 
Anticancer activity and toxicity test 
An anticancer activity test conducted in 
T47D cell culture with RPMI 1640 medium (Gibco, 
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Invitrogen Canada). Furthermore, toxicity test 
performed in Vero cell culture used the M199 
medium (Gibco, Invitrogen Canada). T47D cell 
cultures and Vero cells were grown on 96 well 
plates and then incubated for 24h. After 24h the 
media was removed and washed used PBS, then 
each concentration of extracts was added into each 
well with three replications and incubated for 24h. 
After 24h the media was removed and washed used 
PBS, then added 100μL MTT reagents (Bio Basic 
Inc, Canada) to each well, including media control 
(without cells), then re-incubated for 4h in the CO2 
incubator.  
After 4h the cell condition was observed 
under an inverted microscope, then a 100μL SDS 
10% stopper was added and incubated at room 
temperature overnight. Furthermore the 
absorbance value is read using ELISA reader and 
calculated cell viability using the following formula:  
 
Viability cell =
(Ta –  Mca)
(Cca –  Mca)
× 100% 
 
Ta = Treatment absorbance; Mca = Media control 
absorbance; Cca = Control cell absorbance 
 
The result of viability cell obtained by IC50 
analysis for anticancer activity and CC50 analysis for 
normal cell toxicity using Microsoft Excel (Muti'ah, 
2017). 
 
Flowcytometry test 
The cultured T47D cells as much as 5x105 
cells/well were grown in RPMI medium at 6-well 
plate (for treatment and control cells) then 
incubated for 24h. The cell condition was observed 
in the microscope to see the cell distribution. 
Furthermore, the concentration of the sample and 
doxorubicin was made to the level of IC50. The 6-
well plate that already contain cells taken from the 
incubator. Then, the media cell was removed by 
using a Pasteur pipette slowly and washed with 
PBS. Furthermore, the treatment conducted by 
inserting 2mL extract samples at the first well (for 
cell cycle), 2mL doxorubicin at the second well, and 
2mL cell control at the third well and incubated for 
24h. One conical was prepared for one type of 
treatment or one well. The medium is taken 1mL 
from the well with micropipette and transferred to 
the conical. To the each well, 1mL PBL was added 
1mL PBS and moved into the conical. The conical 
was added 200μL of trypsin-EDTA 0.25% and 
incubated for 3min. Furthermore, the wells were 
added 1mL of control media into each well and 
resuspension until the cells disenganged one by 
one and the cells are transferred to the conical.         
The wells are added 2mL of PBS to retrieve the 
remaining cells, then moved into the conical. The 
conical is centrifuged at 2000 rpm for 5min and the 
supernatant was removed. The each well was 
washed with 1mL PBS again and moved to the 
conical. The conical is resuspended then moved to 
microtube. The microtubes were recentrifuged at 
2000rpm for 3min.  
In cell cycle analysis, the supernatant is 
removed by pouring and added 500μL 70% alcohol 
into the conical while shaking slowly. The conical is 
kept at room temperature (37ᵒC) for 35min and 
recentrifuged at 600rpm for 5min to removed the 
added alcohol from the conical. The conical was 
added 500μL of PBS and centrifuged at 2000rpm 
for 3min. The washing was conducted twice used 
PBS and the conical is wrapped in aluminum foil 
and marked. For apoptotic analysis, the remained 
harvest cells was rinsed used PBS then it was 
centrifuged again and the PBS was removed from 
the conical. The conical was added of Propidium 
Iodide reagent and allowed to stand for 30min. The 
sludge was added PI-Annexin V reagents carefully 
and immediately homogenized. The microtube 
containing the cell suspensions is wrapped in 
aluminum foil and incubated in a 37C water bath 
for 5min. The cells suspension is homogenized and 
transferred into a flow cytometer tube using a 
nylon filter to test for cell cycle and cell apoptosis, 
then ready for analysis with a flow cytometer 
(CCRC, 2009). 
 
RESULTS AND DISCUSSION 
Identification of C. cinerariifolium leaves 
extract chemical compound 
Chemical compounds identification was 
conducted to analyze qualitative content and 
expect phenolic and terpenoid compounds before 
the cytotoxic and apoptosis to be tested. Thin           
Layer Chromatography (TLC) is a physicochemical 
separation method based on two phases, which is a 
fluid phase as a mobile phase and a solid phase as a 
stationary phase (Muti’ah et al., 2013). Based on the 
optimization results showed that the best mobile 
phase were n-Hexane and ethyl acetate (8:2) as 
solvents. After elution and air drying of the plate, 
natural product reagent was sprayed using 10% 
H2SO4 as universal staining.  Furthermore, the plate 
was compared before and after to detection and 
observed the spots characteristic. The result of TLC 
visualizer identification used UV 366 rays shows 
the difference of compound separation between 
before and after spray (Figure 1). 
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It seen in the Rf results obtained, the Rf 
compounds on the TLC plate after spraying more 
than the Rf value on the TLC plate before spraying. 
The number of Rf TLC plate on the leaves extract 
after sprayed is 8.0. The yellow color with 
wavelength 341-389nm after being sprayed 
showed the flavonol group compound, and the 
purple, red color showed terpenoid group 
compounds (Harborne, 1987). Meanwhile, purple 
 
Figure 1. Thin-layer chromatography (TLC) plates of C. cinerariifolium leaves extract stained with 10% 
H2SO4 and visualized under TLC visualizer. A.) Before sprayed under UV 254 nm rays, B.) Before sprayed 
under UV 366 nm rays, C.) After sprayed under white light.  
 
 
Figure 2. Comparison of inhibitory effect of T47D cell growth and Vero cell after treated with extract C. 
Cinerariifolium and Doxorubicin after 24 hours incubation; (A) Control cells; (B) 135.88 µg/ml Doxorubicin 
as positive controls; (C) Treated cells used 600 µg/ml leaves extract. Cell morphology was observed under 
an inverted microscope with magnification 400 times. Alive cells () and dead cells (- ->). Each treatment 
is repeated three times as triplicate. 
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stains are suspected as sesquiterpenes compounds   
(Mutiah et al., 2013). Compounds of flavonoids and 
terpenoid groups play a major role in health, one of 
which is having anticancer activity in breast cancer 
(Bishayee et al., 2011; Weeb and Ebeler, 2004). 
 
Cytotoxic test of C. cinerariifolium leaves extract 
The anticancer activity test of C. 
cinerariifolium leaves extracts known by 
decreasing living cells percentage based on              
50% Inhibitor Concentration (IC50) value. Cell 
morphological observations conducted under an 
inverted microscope after treatment on cells with 
each extract. Comparison of the inhibitory effect of 
T47D cell growth and Vero cell after treated with 
extract C. cinerariifolium (Figure 2). Morphological 
change between T47D control cells using the 
treatment of C. cinerariifolium leaves extract and 
doxorubicin positive control (Figure 2). The form of 
viable T47D cells was elongated, while the dead 
T47D cell was shaped rounded shrink (Iin et al., 
2014). In Vero cells, there was no apparent cell 
death due to the treatment of C. cinerariifolium 
leaves extract compared to control. Morphology of  
viable Vero cells was polygonal and flat (Goncalves, 
2012). The treatment of C. cinerariifolium leaves 
extract possesed cytotoxic activity against human 
cancer cell lines T47D but does exert damage to 
normal vero cells.  To determine the viability of 
cancer cells due to the treatment of C. 
cinerariifolium extract, then tested the cytotoxicity 
of T47D cells and Vero cells used the MTT method. 
The intensity of the purple color that formed is 
proportional to the number of living cells (Doyle 
and Griffiths, 2000). The higher the intensity of the 
purple color indicates a more significant amount of 
living cells (CCRC, 2009). Percentage of cell viability 
in T47D and Vero cells due to the treatment of 
doxorubicin and leaves extract (Figure 3). 
 
Cell cycle due to treatment of C. cinerariifolium 
leaves extract 
Inhibition in the phase of the cell cycle               
that observed was conducted using flow           
cytometry method. The flow cytometry                       
method was a method that can detect every phase 
in the cell cycle based on the number of 
chromosomes  on  each  phase  (G1,  S,  and  G2/M).  
  
 
Figure 3.  The viability cell using MTT method: Percentage graphic of cell viability in T47D cells after 
treatment of C. cinerariifolium leaves extract (left) and doxorubicin treatment (right). Percentage graphic 
of cell viability of Vero cells after treatment of C. cinerariifolium leaves extract (left) and doxorubicin 
treatment (right). This data is repeated three times as triplicate and point of each graphic represented the 
average concentrations. 
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Through this flow cytometry (Figure 4) method, the 
distribution of cells at each phase in the cell cycle 
after treatment could be known. Furthermore, the 
pathway inhibition of C. cinerariifolium leaves 
extracts in blocking the cell cycle could be 
estimated.  
 
Apoptosis induction after treating of C. 
cinerariifolium leaves extract 
In flow cytometry test of C. cinerariifolium 
leaves extracted, the IC50 was 418.8μg/mL and 
compared with doxorubicin at IC50 115.1μg/mL. 
The results of the apoptotic flowcytometry test 
against T47D cells (Figure 5). The colors formed in 
the cell dispersion data were analyzed using a Cell 
Quest program so that the colors formed can be 
separated according to the population. Living cells 
indicated by green, early apoptotic cells exhibited 
by yellow, late apoptosis indicated by pink,             
and  necrosis indicated by red. The resulting colors  
obtained from cells that emit epi-fluorescence due 
to Annexin V or PI bonds which are then captured 
by UV rays (Indradmojo, 2015). 
Anticancer activity on T47D and Vero cell 
and the effects of C. cinerariifolium leaves extract  
on apoptosis induction and regulation of breast 
cancer cycle T47D conducted as the purpose of this 
study. IC50 result obtained from C. cinerariifolium 
leaves extract was 418.8μg/mL, while IC50 
doxorubicin result was 115.1μg/mL (Figure 3).  
The results of IC50 obtained showed that 96% 
ethanol leaves extract of C. cinerariifolium to                
have anticancer activity against breast cancer 
(T47D). An extract has high anticancer activity                
if IC50 <500μg/mL and has weak activity if                     
IC50> 500μg/mL (Costa et al., 2017). The IC50             
result in positive control equal to 115.1μg/mL and 
these result obtained was close to IC50 researchers 
that IC50 doxorubicin value against T47D cells is 
250nM or  135.9μg/mL (Abdolmohammadi, 2008).  
  
 
 
Figure 4. The results of flowcytometry analysis of cell distribution at each phase of cell cycle, A.) control 
cell, B.) treatment of doxorubicin against T47D cells, C.) treatment of Chrysanthemum cinerariifolium leaves 
extract on T47D cells D.) graphic of cell cycle distribution. 
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Doxorubicin has a low IC50 result because it has 
high activity against breast cancer cells (Anjarsari, 
2013). The results of cytotoxic activity test on              
Vero cell (Figure 3) that obtained from IC50 showed 
that 96% ethanol leaves extract of C. cinerariifolium 
has low toxicity to normal cells. The result of               
IC50 leaves extract of C. cinerariifolium in Vero cell 
was 676.182μg/mL, while IC50 doxorubicin                 
value was 1234.5μg/mL. The low toxicity of  
normal cells in vitro tests correlates with high 
levels of safety against normal cells (Mutiah et al., 
2017).  
Percentage analysis of the viability of          
living cells, apoptosis, and necrosis showed 
untreated cells (cell control) had a cell viability 
percentage of 94.47%, 3% apoptotic cells,                 
and 1.82% necrosis cells (Figure 5). While 
doxorubicin-treated cells showed a decrease in cell 
viability to 77.78%, an increase in apoptosis by 
17.13%, and an increase in the number of necrosis 
by   5.18%   when   compared   with    control   cells. 
However, based on the percentage of cell viability 
when compared with the rate of apoptosis and 
necrosis cells, the percentage of living cells still 
more significant than dead cells. It might because 
doxorubicin was able to increase the activity of 
phosphorylation of P13K/ Akt then activate Bcl 
protein which is an antiapoptosis protein and could 
activate Bad protein which is a protein trigger 
apoptosis (Setiawati, 2011).  
In the treatment of ethanol leaves extract               
of C. cinerariifolium showed that T47D cell 
apoptosis induction was 49.88% and necrosis               
was 47.29%, and the living cell was 2.83%              
(Figure 4). The result of statistical analysis of            
three treatments showed a significant difference 
 
 
Figure 5. Result of flowcytometry of apoptotic test against T47D cell A.) control cell, B.) treatment used 
doxorubicin, C.) C. cinerariifolium leaves extract, D.) Comparison graphic of T47D cell population using 
LSD analysis. 
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between apoptosis percentage on cell control, after 
treatment of doxorubicin, and after treatment of 
C.cinerariifolium leaves extract with the 
considerable p-value (p<0.01). The results of the 
statistical analysis of the percentage of cell necrosis 
also showed similar results. The flow cytometry 
analysis conducted used cell quest program (Figure 
5). Cell distribution in each phase of the cell cycle 
was colored used PI reagents as it was able to 
interact with DNA (Putri, 2014). Based on Figure 5 
there was changed in the cell cycle between the C. 
cinerariifolium leaves extract and control cells that 
indicated by the reduction in cell numbers in the 
G0-G1 phase and S phase. These reductions meant 
the cessation of the cell. While in phase M1, the 
control cell was increased which indicates the 
presence of apoptotic cell death. Therefore, the cell 
may couldn't proceed to the next phase (Mutiah et 
al., 2017). Doxorubicin led to cellular inhibition in 
the G0-G1 phase but pointed to the cell shift to the 
right at the G2-M phase indicating that the cell 
enters the phase (Mutiah, 2014). Accumulation 
cells in the G2-M phase causes the down regulation 
of Cdc24c, Cdk1, amd Cyclin B (Su, et al., 2006). 
Inhibiting Cdc2/Cyclin B is one of the result in the 
effect of ATM-ATR signaling, causing G2-M arrest 
(Kolb, et al., 2012).   
The increase of apoptosis by C. 
cinerariifolium leaves extract suspected due to the 
content of flavonoid compounds. Flavonoid 
compounds could induce apoptosis through p53 
pathways. If flavonoids induce apoptosis through 
irreversible DNA damage, then apoptosis was 
possible through the p53 pathway (Meiyanto and 
Septisetyani, 2005). Anticancer activity of C. 
cinerariifolium leaves extract suspected by the 
mechanism of the flavonoid compounds contained 
in the leaves extract of C. cinerariifolium. Flavonoid 
compounds can inhibit the overall performance of 
CDK which is a cell cycle regulator. Inhibition that 
occurs through the working of enzymes CDK-
activating kinase then could inhibit the formation 
of active CDK-cyclin complex (Supriatno and 
Rasmindar, 2014). Proteins that could inhibit the 
CDK-cyclin complex were INK4 and CIP (p21).  
INK4 plays a role in inhibiting progression in G1 
phase. When a G1 phase occurs, the cell 
automatically cannot proceed to the next phase 
(Mutiah, 2014). 
 
CONCLUSION 
In conclusion, the results of the present 
study reveal that ethanol leaves extract of C. 
cinerariifolium could induce 49.88% T47D cell 
apoptosis at IC50 418.8μg/mL concentration, and 
could inhibit cell cycle in phase G0-G1 and S phase 
and increased cell number in phase M1. The 
flavonoid compounds that content in C. 
cinerariifolium supposed could induce apoptosis 
through p53 pathways. The ability of C. 
cinerariifolium ethanol leaves extracts to induce 
apoptosis to suggest that it could be a new 
candidate of anticancer therapy. 
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